RankAlpha logo
Back to Rankings

BEAM

Beam TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
BEAM vs peer average
52/100
BEAM vs. peer average (C vs. C)
Grade spread
B 2 · C 5 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

RCUS is the first available peer comparator.

Arcus Biosciences is a loose SMID-cap biotech peer for funding-risk and catalyst-timing framing, but it is not a direct mechanistic peer to Beam’s base-editing platform.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRCUSArcus Biosciences
BEAM
Beam Therapeutics
RCUS
Arcus Biosciences
Grade
C
C
Momentum
43
78
Value
41
41
Sentiment
72
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs RCUS

BEAM / RCUS
Grade Position
In line
BEAM vs. peer average (C vs. C)
52/100
Momentum
43
RCUS
Value
41
BEAM
Sentiment
72
BEAM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BEAM
1
RCUS
RCUS
C
60/100
Even
2
LQDA
LQDA
C
60/100
Even
3
CLDX
Celldex Therapeutics Inc Common
C
60/100
Even
4
RARE
Ultragenyx Pharmaceutical Inc Common
C
60/100
Even
5
SUPN
Supernus Pharmaceuticals Inc Common
B
80/100
-1
RCUS is the first peer returned for this comparison set.